The present disclosure describes a genetically engineered bacteria that relieves the catabolite repression problem exerted by the Spot 42 small regulatory RNA by adding a galactokinase that does not contain the Spot 42 binding region. As such, galK (galactokinase) and galM (mutarotase) and the like can be expressed allow better galactose utilization.